Literature DB >> 23341348

Insulin-like growth factor pathway genes and blood concentrations, dietary protein and risk of prostate cancer in the NCI Breast and Prostate Cancer Cohort Consortium (BPC3).

Konstantinos K Tsilidis1, Ruth C Travis, Paul N Appleby, Naomi E Allen, Sara Lindström, Demetrius Albanes, Regina G Ziegler, Marjorie L McCullough, Afshan Siddiq, Aurelio Barricarte, Sonja I Berndt, H Bas Bueno-de-Mesquita, Stephen J Chanock, E David Crawford, W Ryan Diver, Susan M Gapstur, Edward Giovannucci, Fangyi Gu, Christopher A Haiman, Richard B Hayes, David J Hunter, Mattias Johansson, Rudolf Kaaks, Laurence N Kolonel, Peter Kraft, Loic Le Marchand, Kim Overvad, Silvia Polidoro, Elio Riboli, Fredrick R Schumacher, Victoria L Stevens, Dimitrios Trichopoulos, Jarmo Virtamo, Walter C Willett, Timothy J Key.   

Abstract

It has been hypothesized that a high intake of dairy protein may increase prostate cancer risk by increasing the production of insulin-like growth factor 1 (IGF-1). Several single nucleotide polymorphisms (SNPs) have been weakly associated with circulating concentrations of IGF-1 and IGF binding protein 3 (IGFBP-3), but none of these SNPs was associated with risk of prostate cancer. We examined whether an association between 16 SNPs associated with circulating IGF-1 or IGFBP-3 concentrations and prostate cancer exists within subgroups defined by dietary protein intake in 5,253 cases and 4,963 controls of European ancestry within the NCI Breast and Prostate Cancer Cohort Consortium (BPC3). The BPC3 includes nested case-control studies within large North-American and European cohorts. Per-allele odds ratios for prostate cancer for the SNPs were compared across tertiles of protein intake, which was expressed as the percentage of energy derived from total, animal, dairy or plant protein sources, using conditional logistic regression models. Total, animal, dairy and plant protein intakes were significantly positively associated with blood IGF-1 (p < 0.01), but not with IGFBP-3 concentrations (p > 0.10) or with risk of prostate cancer (p > 0.20). After adjusting for multiple testing, the SNP-prostate cancer associations did not differ by intakes of protein, although two interactions by intake of plant protein were of marginal statistical significance [SSTR5 (somatostatin receptor 5)-rs197056 (uncorrected p for interaction, 0.001); SSTR5-rs197057 (uncorrected p for interaction, 0.002)]. We found no strong evidence that the associations between 16 IGF pathway SNPs and prostate cancer differed by intakes of dietary protein.
Copyright © 2013 UICC.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23341348      PMCID: PMC3656134          DOI: 10.1002/ijc.28042

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  47 in total

1.  Haplotype-based association studies of IGFBP1 and IGFBP3 with prostate and breast cancer risk: the multiethnic cohort.

Authors:  Iona Cheng; Kathryn L Penney; Daniel O Stram; Loic Le Marchand; Elena Giorgi; Christopher A Haiman; Laurence N Kolonel; Malcolm Pike; Joel Hirschhorn; Brian E Henderson; Matthew L Freedman
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2006-10       Impact factor: 4.254

2.  Calcium intake and prostate cancer risk in a long-term aging study: the Baltimore Longitudinal Study of Aging.

Authors:  Sonja I Berndt; H Ballentine Carter; Patricia K Landis; Katherine L Tucker; Lillian J Hsieh; E Jeffrey Metter; Elizabeth A Platz
Journal:  Urology       Date:  2002-12       Impact factor: 2.649

3.  Impact of nutrients on insulin-like growth factor-I, insulin-like growth factor binding protein-3 and their ratio in African American and white males.

Authors:  Katharine M McGreevy; Brian D Hoel; Stuart R Lipsitz; David G Hoel
Journal:  Public Health Nutr       Date:  2007-01       Impact factor: 4.022

4.  Comprehensive evaluation of genetic variation in the IGF1 gene and risk of prostate cancer.

Authors:  Mattias Johansson; James D McKay; Pär Stattin; Federico Canzian; Catherine Boillot; Fredrik Wiklund; Hans-Olov Adami; Katarina Bälter; Henrik Grönberg; Rudolf Kaaks
Journal:  Int J Cancer       Date:  2007-02-01       Impact factor: 7.396

Review 5.  Circulating insulin-like growth factor peptides and prostate cancer risk: a systematic review and meta-analysis.

Authors:  Mari-Anne Rowlands; David Gunnell; Ross Harris; Lars J Vatten; Jeff M P Holly; Richard M Martin
Journal:  Int J Cancer       Date:  2009-05-15       Impact factor: 7.396

6.  Determinants of circulating insulin-like growth factor I and insulin-like growth factor binding protein 3 concentrations in a cohort of Singapore men and women.

Authors:  Nicole M Probst-Hensch; Hao Wang; Victor H H Goh; Adeline Seow; Hin-Peng Lee; Mimi C Yu
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2003-08       Impact factor: 4.254

7.  Dietary and lifestyle correlates of plasma insulin-like growth factor-I (IGF-I) and IGF binding protein-3 (IGFBP-3): the multiethnic cohort.

Authors:  Katherine DeLellis; Sabina Rinaldi; Rudolph J Kaaks; Laurence N Kolonel; Brian Henderson; Loic Le Marchand
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2004-09       Impact factor: 4.254

8.  IGF-1 and IGFBP-3: Risk of prostate cancer among men in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.

Authors:  Jocelyn M Weiss; Wen-Yi Huang; Sabina Rinaldi; Thomas R Fears; Nilanjan Chatterjee; David Chia; E David Crawford; Rudolf Kaaks; Richard B Hayes
Journal:  Int J Cancer       Date:  2007-11-15       Impact factor: 7.396

9.  A prospective study of demographics, diet, and prostate cancer among men of Japanese ancestry in Hawaii.

Authors:  R K Severson; A M Nomura; J S Grove; G N Stemmermann
Journal:  Cancer Res       Date:  1989-04-01       Impact factor: 12.701

10.  A cross-sectional analysis of the association between diet and insulin-like growth factor (IGF)-I, IGF-II, IGF-binding protein (IGFBP)-2, and IGFBP-3 in men in the United Kingdom.

Authors:  Nicholas J Young; Chris Metcalfe; David Gunnell; Mari-Anne Rowlands; J Athene Lane; Rebecca Gilbert; Kerry N L Avery; Michael Davis; David E Neal; Freddie C Hamdy; Jenny Donovan; Richard M Martin; Jeff M P Holly
Journal:  Cancer Causes Control       Date:  2012-04-21       Impact factor: 2.506

View more
  17 in total

Review 1.  Risk of Neoplasia in Pediatric Patients Receiving Growth Hormone Therapy--A Report From the Pediatric Endocrine Society Drug and Therapeutics Committee.

Authors:  Sripriya Raman; Adda Grimberg; Steven G Waguespack; Bradley S Miller; Charles A Sklar; Lillian R Meacham; Briana C Patterson
Journal:  J Clin Endocrinol Metab       Date:  2015-04-03       Impact factor: 5.958

2.  Design and analysis considerations for combining data from multiple biomarker studies.

Authors:  Abigail Sloan; Yue Song; Mitchell H Gail; Rebecca Betensky; Bernard Rosner; Regina G Ziegler; Stephanie A Smith-Warner; Molin Wang
Journal:  Stat Med       Date:  2018-12-19       Impact factor: 2.373

3.  Dairy intake and semen quality among men attending a fertility clinic.

Authors:  Myriam C Afeiche; Naima D Bridges; Paige L Williams; Audrey J Gaskins; Cigdem Tanrikut; John C Petrozza; Russ Hauser; Jorge E Chavarro
Journal:  Fertil Steril       Date:  2014-03-14       Impact factor: 7.329

4.  IGFBP3 polymorphisms and risk of esophageal cancer in a Chinese population.

Authors:  Chao Liu; Weifeng Tang; Shuchen Chen; Yafeng Wang; Hao Qiu; Jun Yin; Haiyong Gu
Journal:  Int J Clin Exp Med       Date:  2015-09-15

5.  STATISTICAL METHODS FOR ANALYSIS OF COMBINED CATEGORICAL BIOMARKER DATA FROM MULTIPLE STUDIES.

Authors:  Chao Cheng; Molin Wang
Journal:  Ann Appl Stat       Date:  2020-09-18       Impact factor: 2.083

6.  Interactions Between Genome-Wide Significant Genetic Variants and Circulating Concentrations of 25-Hydroxyvitamin D in Relation to Prostate Cancer Risk in the National Cancer Institute BPC3.

Authors:  Vasiliki I Dimitrakopoulou; Ruth C Travis; Irene M Shui; Alison Mondul; Demetrius Albanes; Jarmo Virtamo; Antonio Agudo; Heiner Boeing; H Bas Bueno-de-Mesquita; Marc J Gunter; Mattias Johansson; Kay-Tee Khaw; Kim Overvad; Domenico Palli; Antonia Trichopoulou; Edward Giovannucci; David J Hunter; Sara Lindström; Walter Willett; J Michael Gaziano; Meir Stampfer; Christine Berg; Sonja I Berndt; Amanda Black; Robert N Hoover; Peter Kraft; Timothy J Key; Konstantinos K Tsilidis
Journal:  Am J Epidemiol       Date:  2017-03-15       Impact factor: 4.897

7.  Childhood height and birth weight in relation to future prostate cancer risk: a cohort study based on the copenhagen school health records register.

Authors:  Michael B Cook; Michael Gamborg; Julie Aarestrup; Thorkild I A Sørensen; Jennifer L Baker
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-10-02       Impact factor: 4.254

8.  Analysis of cytosine-adenine repeats in P1 promoter region of IGF-1 gene in peripheral blood cells and cervical tissue samples of females with cervical intraepithelial lesions and squamous cervical cancer.

Authors:  Wojciech Kwasniewski; Anna Gozdzicka-Jozefiak; Maria Kotarska; Grzegorz Polak; Bartlomiej Barczynski; Justyna Broniarczyk; Witold Nowak; Maria Wolun-Cholewa; Anna Kwasniewska; Jan Kotarski
Journal:  Mol Med Rep       Date:  2014-11-10       Impact factor: 2.952

Review 9.  Understanding the Key to Targeting the IGF Axis in Cancer: A Biomarker Assessment.

Authors:  Kunal Amratlal Lodhia; Piyawan Tienchaiananda; Paul Haluska
Journal:  Front Oncol       Date:  2015-07-08       Impact factor: 6.244

10.  Height, selected genetic markers and prostate cancer risk: results from the PRACTICAL consortium.

Authors:  Artitaya Lophatananon; Sarah Stewart-Brown; Zsofia Kote-Jarai; Ali Amin Al Olama; Sara Benlloch Garcia; David E Neal; Freddie C Hamdy; Jenny L Donovan; Graham G Giles; Liesel M Fitzgerald; Melissa C Southey; Paul Pharoah; Nora Pashayan; Henrik Gronberg; Fredrik Wiklund; Markus Aly; Janet L Stanford; Hermann Brenner; Aida K Dieffenbach; Volker Arndt; Jong Y Park; Hui-Yi Lin; Thomas Sellers; Chavdar Slavov; Radka Kaneva; Vanio Mitev; Jyotsna Batra; Amanda Spurdle; Judith A Clements; Douglas Easton; Rosalind A Eeles; Kenneth Muir
Journal:  Br J Cancer       Date:  2017-08-01       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.